1. Dashboard

Pfizer NYSE: PFE

Invest Fact Sheet
Name Pfizer
Ticker PFE
Exchange NYSE
Sector Health Care
Industry Drug Manufacturers - Diversified
Price 36.17
52W Low/High 28.49 / 40.71
Market cap 201 B
1Y Total Return 4.84%
Above Average
1Y Volatility 32.91%
Low Risk
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions

Details

Ticker PFE
Name Pfizer
ISIN US7170811035
CUSIP 717081103
Exchange NYSE
Sector Health Care
Industry Drug Manufacturers - Diversified
Country USA
Currency U.S. Dollar
In Index(ices)
  • US S&P 500 Index
  • US S&P 100 Index

Share as of 9/29/20

Close Price 36.17
52W Low/High 28.49 / 40.71
Market cap 201 B
1Y Total Return 4.84%
Above Average
1Y Volatility 32.91%
Low Risk
Beta 0.97
PE (trailing) 14.30
Below Average
12M Dividends 1.48
Last Dividend Date 7/30/20
Dividend Yield 4.09%

Fin. Strength

Net Profit Margin 28.8%
Cash from Op. / Cur. Liabilities 0.46
Diluted Earnings / Share 2.53
ROE 22.9%
ROIC 9.7%
Price / Revenue 4.1
Price / Book 3.2
Price / CF 13.6
Current Ratio 1.4
Cur.Liabilities / Tot.Liabilities 0.3
Financial Leverage 0.99
in Mils USD
rolling-year up to June
 
Income Statement 2020 2019 2018 2017 2016 2015  
Revenue
49,197
53,657
53,243
52,348
52,286
48,196
Gross Profit
39,328
42,879
41,664
40,924
40,632
39,108
R&D
8,962
8,010
7,721
7,916
7,549
8,630
EBITDA
22,436
17,999
19,411
16,221
13,790
17,081
Operating Income
8,962
11,694
13,193
10,147
8,313
12,014
Net Income exc. Extra
14,171
12,651
22,547
8,324
7,043
8,896
per Share  
Diluted avg Shares
5,619
5,672
5,952
6,037
6,149
6,243
EPS exc. Extra
2.53
2.21
3.74
1.37
1.13
1.41
Dividend
1.48
1.40
1.32
1.24
1.16
1.10
  
Div. Yield (an.)
4.62%
3.23%
3.64%
3.69%
3.26%
3.13%
  
Balance Sheet 2020 2019 2018 2017 2016 2015  
Total Assets
177,934
156,199
164,980
168,558
170,658
160,878
Cash, Eq & Invt ShortTerm
22,794
12,912
13,431
14,333
20,942
30,256
Total Current Assets
46,424
47,073
37,303
36,385
43,845
51,715
Total Non-Current Assets
131,510
109,126
127,677
132,173
126,813
109,163
Intangibles
91,990
86,376
102,420
106,362
93,656
74,995
Total Liabilities
113,370
96,274
94,856
109,863
107,592
93,698
Total Current Liabilities
32,723
32,030
32,156
27,182
32,099
24,143
Long Term Debt
80,647
64,244
62,700
82,681
75,493
69,555
Shareholder equity
64,336
59,568
69,778
58,368
62,769
66,894
Cash Flow 2020 2019 2018 2017 2016 2015  
Cash from Operations
14,967
14,306
17,808
15,602
15,332
14,636
Depreciation
5,406
6,328
6,269
6,074
5,508
5,118
Cash from Investing
-22,675
1,980
423
-4,438
-7,790
438
Capex
2,363
2,560
2,212
2,048
1,785
1,466
Cash from Financing
7,792
-17,131
-18,082
-11,871
-6,810
-14,670
Stock Issued
304
-13,967
-5,138
-4,266
-4,182
-7,080
Debt (LT) Issued
16,215
5,139
-3,904
470
4,734
-1,001
Free Cash Flow
17,820
16,022
33,288
6,702
16,280
17,414
Ratios 2020 2019 2018 2017 2016 2015  
Net Profit Margin
28.8%
23.6%
42.3%
15.9%
13.5%
18.5%
  
NCFO / Op.Income
167.0%
122.3%
135.0%
153.8%
184.4%
121.8%
  
Current Ratio
1.4
1.5
1.2
1.3
1.4
2.1
  
Financial Leverage D/E
0.99
0.78
0.58
0.75
0.70
0.53
  
Return on Capital Avg
9.7%
9.9%
18.8%
5.8%
5.5%
6.6%
  
Return on Shareholder Equity
22.9%
19.6%
35.2%
13.7%
10.9%
12.4%
  

Data

Fundamentals

More Info

No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available